MFS
AST.WS

MSI Financial Services’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

MSI Financial Services’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6
Closed – – 4251
2016
Q3 		$0 Hold
6
– – ﹤0.01% 4284
2016
Q2 		$0 Buy
+6
New +$3 ﹤0.01% 4332

Other funds holding AST.WS

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

MSI Financial Services's AST.WS Position: Q4 2016 in Review

MSI Financial Services sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q4 2016, closing a stake of 6 shares.

MSI Financial Services first reported a position in AST.WS in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 36 funds tracked by Wall St. Rank hold AST.WS as of Q4 2016.

  • MSI Financial Services reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q4 2016 after selling out during the quarter.
  • MSI Financial Services sold 6 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q4 2016.
  • MSI Financial Services first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 2 quarters.
  • MSI Financial Services's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q3 2016.
  • 36 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.